{"name":"Smith+Nephew plc","slug":"smith-nephew","ticker":"SNN","exchange":"NYSE","domain":"smith-nephew.com","description":"Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image ","hq":"London, United Kingdom","founded":1950,"employees":"16988","ceo":"Deepak Nath","sector":"MedTech / Orthopedics & Wound Management","stockPrice":29.77,"stockChange":-0.05,"stockChangePercent":-0.17,"marketCap":"$12.7B","metrics":{"revenue":6163999744,"revenueGrowth":7.4,"grossMargin":68.3,"rdSpend":0,"netIncome":625000000,"cash":557000000,"dividendYield":2.62,"peRatio":20.8,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-01","type":"earnings","headline":"Smith+Nephew Reports Strong Q4 and Full-Year 2023 Results","summary":"Smith+Nephew reported strong Q4 and full-year 2023 results, driven by growth in its orthopedic and wound management businesses.","drugName":"","sentiment":"positive"},{"date":"2023-09-01","type":"deal","headline":"Smith+Nephew Acquires OrthoSpace","summary":"Smith+Nephew acquired OrthoSpace, a French company that specializes in orthopedic implants for shoulder and elbow reconstruction.","drugName":"","sentiment":"positive"},{"date":"2023-06-01","type":"regulatory","headline":"Smith+Nephew Receives FDA Clearance for JOURNEY II Total Knee System","summary":"Smith+Nephew received FDA clearance for its JOURNEY II Total Knee System, a new orthopedic implant for knee replacement surgery.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxORTl6ZTJyYmx5UHA0VjFLZnBEVUtXbFJNSzQyLUZhME9xbnVCSnJ5bFRCSnFrMHprTEtkTFktN3U0SEVzdkFlNlRIQjFmTTktc2djbnNURWZXVjNHX3Y3X203M3p5Y1VlNFVyLThwZ2lxOVRqUWpueU03MDZaQmNaVTBXRmtIbUFPUmJNSmJJZ1NBbDhodFlfRDNBcHJVQWUxeWt4dEkwc0NhbnZQVUkwQ2pMREdCUXNFMlY3NzJOdw?oc=5","date":"2026-03-10","type":"pipeline","source":"Quantisnow","summary":"Smith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention - Quantisnow","headline":"Smith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound mana","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNdHdRcUJQRzE1SVJUMUJxbU94VWhXc2hUQUVPeFFpVTZVaW5BR1F4a1VOYkVLWVBWUDZkMWtMZUJUSE9sTWJuYzl2SVR3RlhHZjlwb2NiLWJldF9NTHhnSm9GSFVIYzEtNDlJb1MwYTExUlpQTjVtM0ZzUUIwOTR3YktOV3hTRmFJTGZXNk0xeElVUm9oc3Z1Nk81VXZRSExlNDQ0VGJpY3Q4S3FTNzdXci02UTFONjRl?oc=5","date":"2026-02-24","type":"deal","source":"Stock Titan","summary":"Nitinol fracture implant deal expands Smith+Nephew’s US reach - Stock Titan","headline":"Nitinol fracture implant deal expands Smith+Nephew’s US reach","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOdktBZW5WZ1ZXV05JUGFxMEZXQXlBbU1NVXZEakRDUnQ3dy12Nk9LR3RRQ3JVTFNNZzQ3WkZmWWU3bVY1V0haOE11a1NuT3lhRXZnNUlHZUVpSDBBZHVtdlh1aXdON3E1V0I3ZTU2VzIxR0JaWldMdE4wX012djMyOTZSLXNGQzE2VGVqY0FjT3Z3OVdlNGFuNHVR?oc=5","date":"2026-02-24","type":"pipeline","source":"BioSpace","summary":"Smith+Nephew signs distribution agreement with SI-BONE - BioSpace","headline":"Smith+Nephew signs distribution agreement with SI-BONE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPVzR4MnpncGxqWWlEazJOOUN3Q3JzbXRRcW16d2RabUt6VzJEdjBhSEVLZG41c1NVU1ZpZTU1S2hQQUVzWU15cmdEbE5JR1JMNkJEQU9WLTZaeXdWUlh0MFlrYlQ4cFk5MWJGVzV0MS1rWHdkTU1zTE5vODFQNFpxSGVuSE9oRmQyUWZzQVRnZ0VzTWNxaUlCSEp3YW9WY0swMTJRYW5wYTB3dTdTZUhGOWFCYTk?oc=5","date":"2026-01-12","type":"deal","source":"Reuters","summary":"UK's Smith & Nephew to buy Integrity Orthopaedics for up to $450 million - Reuters","headline":"UK's Smith & Nephew to buy Integrity Orthopaedics for up to $450 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPelFOZXg0SHA1WmtsM0xMMFZHTWVEZy01d0ZzMFZidUw4Mmp5MkhGT3RDWTNZXzhlSjdkaF94WnNVaDZBcnVic1NHWTMzNThnenMxal8wdkVMcUdOYUxSRHNYZmtKSVhxRTZ5U0VXaHFPSGZKVzhJeXlySU4zT1p4M1FNc1lBd2hvdHlWQ05ET1p0Y0JkR1JLTDVXcUJyQkp4S2xONw?oc=5","date":"2026-01-07","type":"pipeline","source":"Seeking Alpha","summary":"Smith & Nephew: Improving And Undervalued, But Mind The Knees - Seeking Alpha","headline":"Smith & Nephew: Improving And Undervalued, But Mind The Knees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOSzhBWFdRQURlS1RBYnN4SFZJSzNHb0FaUW5XYjZod2J6YXVRVXZtY19XYjhWNlNqbGFIdXQydDdYRVJSenRCQjhBTnVhdlpMMC0zdGhncXpiX3NLaG5NV200b0xhRE9OeW5FaHJoWFBZYmN0MkJxOGpkaW8zZWpma09DRmZublAtd2h6OElMWktnZE5PR0VmSzhVSC1OX29oWDdNUUlpZTljNE9OMUdqY21ybnVJUHdsZkE?oc=5","date":"2025-11-05","type":"earnings","source":"Seeking Alpha","summary":"Smith & Nephew: Expensive Valuations And Muted Growth May Dampen Upcoming Q3 Earnings Release - Seeking Alpha","headline":"Smith & Nephew: Expensive Valuations And Muted Growth May Dampen Upcoming Q3 Earnings Release","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQTE9YRzViSTU4NGpycmhNUzhQTElUR0xuMlZmTWRYWFVVSU9tSWJjVEh4Y2lDMlhpRHd4bWtMU0VweHp2MWxJX0xseEg5eDdDZzZVaUZYVjZyeW5mU3NQYjdCbW9Jdlh3aUhLT2lfX1YxclpXU3dEcUpia3E2REZZREktSFJ4MGhPdXE0Rk1ra0ZFOU1QUlUza25Rb1k1LVJMNGpEdml6VzN4NF9ZZVpGYURqZjd4cjdsTE1kTFV3?oc=5","date":"2025-10-27","type":"trial","source":"Stock Titan","summary":"Smith+Nephew (NYSE: SNN) 22,000-patient study: PICO cuts dehiscence 63.9% vs Prevena - Stock Titan","headline":"Smith+Nephew (NYSE: SNN) 22,000-patient study: PICO cuts dehiscence 63.9% vs Prevena","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE9fY2RCTDFGWFJQS2wzeWtnVElCcnhPbmozVERMS1p5cVRVcVZTTnRsc0phYTJVcjY0NVJGalJ1N3lyOFV3bWZsZ1VZcFd0SEJhU3EtcHhFd0IxbVFuZ0xHbTg0MUlOamFPdkpIa25mNTgwQW42ZkE?oc=5","date":"2025-10-09","type":"pipeline","source":"TradingKey","summary":"SNN|Smith & Nephew PLC|Price:32.140|Chg%:0.04 - TradingKey","headline":"SNN|Smith & Nephew PLC|Price:32.140|Chg%:0.04","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQQ1VINmlLMW1lRlJqRHFyZUpKQ2wyamFtT1BiMldKdGVqbGZZXzA3V2czVWdTcUd1ckhqZnlWRnplcDlON1JOREMxa2Z1V1M0X1NVc1lnLWgtLVlrQ3M5RS1sbC05eldEeVVhcWR5S1NZbFQ5dmVZMURRbllHbWQ2NmhBdi0xSTNFOVFyS3JfTzJiQUVLTGcxdENEcmkyZnBJbGN1TGd6WnNhR3N0Ni0xWlFmQWhFc0cwaFE?oc=5","date":"2025-09-03","type":"pipeline","source":"Stock Titan","summary":"Smith+Nephew Launches CENTRIO PRP System for Wound Care in US | SNN Stock News - Stock Titan","headline":"Smith+Nephew Launches CENTRIO PRP System for Wound Care in US | SNN Stock News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQYmRrUG5pdWZDTGUzQzdOUV9taUk5bUp4a3V0LXJpbVRyeTN5NklkR1FLc1lLT29idXdIQ3oyQlhVUGxsZWg5R1dDeXh4SV8tYWlzRk1rdDNoYmxfUjFVTHVicFI0cy1SU0pKbzljbm1Ebi1EYzM5anEzUlZncXRmVnZQWUdBSE55SFg2U1o0XzhJQ3lRWS1mWkZJOXhzMGdDTDhiMDVGMA?oc=5","date":"2025-08-05","type":"earnings","source":"Seeking Alpha","summary":"Smith & Nephew plc 2025 Q2 - Results - Earnings Call Presentation (NYSE:SNN) 2025-08-05 - Seeking Alpha","headline":"Smith & Nephew plc 2025 Q2 - Results - Earnings Call Presentation (NYSE:SNN) 2025-08-05","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxPcVVnYmhmYkhXR21Ub2xaTFFGWkw4V0UzZkNzQVhGY2Z3NG8zNkRRUEJrRjFDODdYZmxBcVMtLUF5dnBpVjlPSlJWX1h1eGIxT0pyVE9xaFVzMmxaN1ZzSDVqVHFRWmJST2FXc0liTzF1YjczY1lvczBTVzBZeU4weGo5NVZna1d6OFJfV0c2azN0M25ONnBjV2s2Z1poV1ZSS2J2LXZEQnMxTEIzTnpBWEZ6S0VjTFpCQnFESjdNaDJYR3BfT1hEdU5PMXBkdk1XUVJrNi1Tb0M1YXVBQXRlZzVSOFZlZjR5N2JXUUMxLVBsOXVzLV9GNEt6WQ?oc=5","date":"2023-06-12","type":"pipeline","source":"PR Newswire","summary":"Smith+Nephew announces 510(k) clearance of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement - PR Newswire","headline":"Smith+Nephew announces 510(k) clearance of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNWmZzWi1aMXFKbE5MY1VTak9MQmlKOWUzVXJ2RzgyZHo2ckI3b250bGNUYlgwaVdpbzJ1YUQ0SWl5aTdFRTRWV1J4azJJVXNtVjE1a3VvaW5lb0FNaG43VmMtbURnNFNDTmRUNm5SNE5aZVNURGNPN0FwRzlZekVMR05xZ0ZTMHc0R01KdU5n?oc=5","date":"2017-12-01","type":"deal","source":"MassDevice","summary":"Smith & Nephew deals topical anesthetic gel to Alliance Pharma - MassDevice","headline":"Smith & Nephew deals topical anesthetic gel to Alliance Pharma","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Johnson & Johnson","Stryker","Zimmer Biomet"],"therapeuticFocus":["Orthopedic Reconstruction","Sports Medicine","Wound Management"],"financials":{"source":"yahoo_finance","revenue":6164000000,"revenuePeriod":"2025-12-31","revenueHistory":[{"period":"2025-12-31","value":6164000000},{"period":"2024-12-31","value":5810000000},{"period":"2023-12-31","value":5549000000},{"period":"2022-12-31","value":5215000000}],"grossProfit":4192000000,"grossProfitHistory":[{"period":"2025-12-31","value":4192000000},{"period":"2024-12-31","value":4046000000},{"period":"2023-12-31","value":3819000000},{"period":"2022-12-31","value":3675000000}],"rdSpend":296000000,"rdSpendHistory":[{"period":"2025-12-31","value":296000000},{"period":"2024-12-31","value":289000000},{"period":"2023-12-31","value":339000000},{"period":"2022-12-31","value":345000000}],"sgaSpend":2790000000,"operatingIncome":857000000,"operatingIncomeHistory":[{"period":"2025-12-31","value":857000000},{"period":"2024-12-31","value":860000000},{"period":"2023-12-31","value":620000000},{"period":"2022-12-31","value":634000000}],"netIncome":625000000,"netIncomeHistory":[{"period":"2025-12-31","value":625000000},{"period":"2024-12-31","value":412000000},{"period":"2023-12-31","value":263000000},{"period":"2022-12-31","value":223000000}],"eps":1.432,"epsHistory":[{"period":"2025-12-31","value":1.432},{"period":"2024-12-31","value":0.94},{"period":"2023-12-31","value":0.602},{"period":"2022-12-31","value":0.5}],"cash":557000000,"cashHistory":[{"period":"2025-12-31","value":557000000},{"period":"2024-12-31","value":619000000},{"period":"2023-12-31","value":302000000},{"period":"2022-12-31","value":350000000}],"totalAssets":10457000000,"totalLiabilities":5168000000,"totalDebt":3327000000,"equity":5289000000,"operatingCashflow":1285000000,"operatingCashflowHistory":[{"period":"2025-12-31","value":1285000000},{"period":"2024-12-31","value":987000000},{"period":"2023-12-31","value":608000000},{"period":"2022-12-31","value":468000000}],"capex":-433000000,"capexHistory":[{"period":"2025-12-31","value":-433000000},{"period":"2024-12-31","value":-381000000},{"period":"2023-12-31","value":-427000000},{"period":"2022-12-31","value":-358000000}],"freeCashflow":852000000,"dividendsPaid":-330000000,"buybacks":-502000000,"employees":16988,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":29.77,"previousClose":29.82,"fiftyTwoWeekHigh":38.79,"fiftyTwoWeekLow":28.23,"fiftyTwoWeekRange":"28.23 - 38.79","fiftyDayAverage":32.38,"twoHundredDayAverage":34.28,"beta":0.67,"enterpriseValue":28109893632,"forwardPE":13.7,"priceToBook":11.96,"priceToSales":2.06,"enterpriseToRevenue":4.56,"enterpriseToEbitda":21.04,"pegRatio":1.21,"ebitda":1336000000,"ebitdaMargin":21.7,"freeCashflow":876625024,"operatingCashflow":1284999936,"totalDebt":3327000064,"debtToEquity":62.9,"currentRatio":2.57,"returnOnAssets":5.3,"returnOnEquity":11.8,"analystRating":"2.6 - Hold","recommendationKey":"hold","numberOfAnalysts":5,"targetMeanPrice":34.99,"targetHighPrice":40,"targetLowPrice":30,"dividendRate":0.78,"payoutRatio":0.53,"fiveYearAvgDividendYield":2.55,"exDividendDate":1774569600,"insiderHeldPercent":0,"institutionHeldPercent":7.2,"sharesOutstanding":426824573,"floatShares":839972450,"sharesShort":2950605,"shortRatio":2.9,"shortPercentOfFloat":0.7,"epsTrailing":1.43,"epsForward":2.18,"revenuePerShare":2.84,"bookValue":2.49,"officers":[{"age":53,"name":"Dr. Deepak S. Nath Ph.D.","title":"CEO & Director"},{"age":56,"name":"Mr. John Terence Rogers","title":"CFO & Executive Director"},{"age":57,"name":"Mr. Paul  Connolly","title":"President of Global Operations"},{"age":null,"name":"Emily  Heaven","title":"Head of Investor Relations"},{"age":46,"name":"Ms. Helen  Barraclough","title":"Group General Counsel & Company Secretary"},{"age":53,"name":"Ms. Alison  Parkes","title":"Chief Compliance Officer & Compliance APAC"},{"age":null,"name":"Mr. Charles  Reynolds","title":"Head of Corporate Communication"},{"age":54,"name":"Dr. Ajay  Dhankhar Ph.D.","title":"Chief Corporate Development & Strategy Officer"}],"industry":"Medical Devices","irWebsite":"http://global.smith-nephew.com/master/investor_centre_2738.htm","website":"https://www.smith-nephew.com","phone":"44 1923 477 100"}}